Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Leodolter

Showing results (151-160 of 168) with videos related to

Pageof 17
Sort By:
Cancer|February 26, 1998
The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigenA Obermair, C Wanner, S Bilgi, et al.
British Journal of Cancer|May 1, 1993
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancerA Rosen, P Sevelda, M Klein, et al.
International Journal of Cancer|August 22, 1997
Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survivalA Obermair, E Kucera, K Mayerhofer, et al.
Cancer Genetics and Cytogenetics|August 25, 2001
High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinomaI Pribill, P Speiser, J Leary, et al.
Wiener Klinische Wochenschrift|January 1, 1992
[Mucoviscidosis screening with immunoreactive trypsin]E Eber, H Ellemunter, H Engele, et al.
Anticancer Research|April 13, 2001
Paclitaxel-carboplatin chemotherapy does not cause encephalopathy in patients with ovarian cancer: a prospective EEG mapping study in 28 patientsK Mayerhofer, K Bodner, B Saletu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samplesC Hruza, K Dobianer, A Beck, et al.
Oncogene|September 1, 1990
Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolationF D Kury, C Schneeberger, G Sliutz, et al.
Gynecologic Oncology|December 1, 1995
DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancerM Medl, P Sevelda, K Czerwenka, et al.
Gynecologic Oncology|May 2, 2001
Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patientsK Bodner, B Bodner-Adler, A Obermair, et al.
Pageof 17

Showing results (151-160 of 168) with videos related to

Sort By:
Pageof 17
Cancer|February 26, 1998
The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigenA Obermair, C Wanner, S Bilgi, et al.
British Journal of Cancer|May 1, 1993
First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancerA Rosen, P Sevelda, M Klein, et al.
International Journal of Cancer|August 22, 1997
Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survivalA Obermair, E Kucera, K Mayerhofer, et al.
Cancer Genetics and Cytogenetics|August 25, 2001
High frequency of allelic imbalance at regions of chromosome arm 8p in ovarian carcinomaI Pribill, P Speiser, J Leary, et al.
Wiener Klinische Wochenschrift|January 1, 1992
[Mucoviscidosis screening with immunoreactive trypsin]E Eber, H Ellemunter, H Engele, et al.
Anticancer Research|April 13, 2001
Paclitaxel-carboplatin chemotherapy does not cause encephalopathy in patients with ovarian cancer: a prospective EEG mapping study in 28 patientsK Mayerhofer, K Bodner, B Saletu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samplesC Hruza, K Dobianer, A Beck, et al.
Oncogene|September 1, 1990
Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolationF D Kury, C Schneeberger, G Sliutz, et al.
Gynecologic Oncology|December 1, 1995
DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancerM Medl, P Sevelda, K Czerwenka, et al.
Gynecologic Oncology|May 2, 2001
Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patientsK Bodner, B Bodner-Adler, A Obermair, et al.
Pageof 17